The Incredible Story of Laetrile Part III: A Cancer Cure Cover-Up? The Conclusion

Editor’s Note: This article is Part 3 of a 3-part series on an incredible cancer-fighting compound known as laetrile, and first appeared in the April 2017 edition of TTAC’s Heroes Against Cancer member newsletter.

As we discovered in Parts 1 and 2 of this series, amygdalin or vitamin B-17 – known in its concentrated and purified form developed especially for cancer therapy by Dr. Krebs Jr. as Laetrile – is selectively toxic to cancer cells without affecting normal, non-cancerous cells.